OBIO
Orchestra BioMed Holdings Inc.
5.90$
-4.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -459.1% | – | -829.0% | -1,671.3% | -1,916.5% | -146.2% | |
| 2.4% | – | 6.3% | 10.4% | 11.7% | 1.0% | |
| 3.9% | – | 96.6% | 276.3% | 402.4% | 35.8% | |
| 56.5% | – | – | – | – | – | |
| -142.4% | – | -12.8% | -119.8% | -29.0% | -31.0% | |
| 9.5% | – | 16.7% | 2.8% | 11.0% | 1.5% | |
| 472.8% | – | -1,814.9% | 387.2% | 496.2% | -80.5% | |
| – | – | -2,620.7% | – | – | – | |
| 175.3% | – | 100.6% | -393.1% | 568.6% | 0.0% | |
| 175.3% | – | 2,922.6% | 1,674.5% | 1,105.8% | 263.8% | |
| 189.1% | – | 278.7% | 390.4% | -314.6% | 37.1% | |
| -468.6% | – | -845.7% | -1,674.1% | -1,927.5% | -147.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.